TrialHaematologica2024

Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.

Elisa Jacobsen Pulczynski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.